Ocular Therapeutix OCUL shares are trading higher on Wednesday after the company announced its third-quarter preliminary net product sales.
Ocular Therapeutix is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye.
Ocular Therapeutix shares traded up 19.68% to $10.06 on Wednesday. The stock has a 52-week high of $10.23 and a 52-week low of $2.46.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: Newswhy it's moving
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in